INSTRUCTIONS FOR AUTHORS
Current Allergy and Clinical Immunology Author’s Guidelines
Current Allergy & Clinical Immunology publishes articles concerned with the understanding and practice of allergic diseases or clinical immunology. Material submitted for publication to Current Allergy & Clinical Immunology is accepted on condition that it has not been published elsewhere. The journal maintains the copyright of the material published. All named authors must give consent to publish. The views expressed in this publication are
those of the authors and not necessarily those of the sponsors or publishers.
All articles will be subjected to peer review. Articles should be submitted by email to email@example.com.
Original Research: Original articles should be a maximum of 3500 words with no more than 3 figures and 3 tables. An abstract of no more than 200 words must be included with the following headings: introduction, methods, results, conclusion. Five keywords should be provided.
Case Reports: Case reports should not exceed 2000 words, with a maximum of 3 figures, 3 tables and 10 references and must have a summary of not more than 50 words.
Each article should have a title page including the title of the articles and authors’ details. Authors should state their full name, qualifications, institutional affiliation and provide a corresponding address and email address. The type of article should also be specified.
The following declarations must be stated at the end of the manuscript before the references:
- Declaration of conflict of interest: Authors should disclose any relationship within the last 2 years with pharmaceutical companies in the following categories, if pertinent to the article: research grants, educational support (sponsorship at conferences), advisory boards, consultant or shares in companies.
- Funding source.
- Plagiarism: The authors acknowledge that the Editorial Board reserves the right to use plagiarism detection software on any submitted material.
- Ethics approval must be included with all original research articles.
All abbreviations must be spelt out when first used and thereafter used consistently.
Tables and Figures
Tables must be numbered with Roman numerals, thus: I, II, III, etc. and illustrations/figures with Arabic numerals, thus 1, 2, 3, etc.
Images must be submitted separately from the manuscript file as high-resolution jpg or png files, and clearly labelled. Images should NOT be submitted in Powerpoint format or be included in the MSWord document. The source of the images must be provided.
Please ensure identification of patients is not possible from images.
- References should be inserted in the text, as superscript numbers, and should be listed at the end of the article in numerical order.
- References must be set out in the Vancouver Referencing style and only approved abbreviations of journal titles should be used. Names and initials of all authors must be given unless there are more than six, in which case the first three names must be given followed by ‘et al’. First and last page numbers must be given. Digital Object Identifiers (DOI) must be provided where possible. Example:
Khakoo G, Lack G. Recommendations for using MMR vaccine in children allergic to eggs. BMJ 2000;320:929–32.
References for books must include the author’s surname and initials. Title of chapter. In: Editor’s surname initials, editor. Title of the book. #ed. [if not 1st] Place of publication: Publisher’s name; Year of publication. p. #. [page numbers of chapter]. Example:
Gallati S. Genetics, pathophysiology and epidemiology of CF. In: Eber E, Medulla F, editors. Paediatric Respiratory Handbook. 1st ed. Sheffield: European Respiratory Society; 2013. p.390–396.
Website references should include the date last accessed. Example: Allergic rhinitis guideline. www.allergysa.org (accessed 12 August 2011).
- ‘Unpublished observations’ and ‘personal communications’ may be cited in the text, but not in the reference list. Articles accepted but not yet published can be included as references followed by ‘(in press)’